Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial. (nature.com)

Authors: Kwon JM … van der Pol WL Journal: Nature Medicine Published: 2026-02-01 DOI: https://doi.org/10.1038/s41591-025-04119-2